Biological E, Recbio collaborate to produce HPV9 vaccine
Recbio to complete technology transfer while BE will manufacture HPV9 vaccine for India, UNICEF and PAHO tender markets
Author
ICT Mumbai’s Dr Prajakta Dandekar Jain selected as founding member of INSA Women Associates
The INSA Women Associates (IWA) initiative aims to foster greater inclusion and leadership opportunities for women across…
Romaco earns Gold EcoVadis sustainability rating
The Romaco Group’s assessment included all six production sites: Karlsruhe, Cologne and Steinen in Germany; Bologna, Italy;…
Hyderabad: Accelerating the future of life sciences
Anshuman Magazine, Chairman & CEO – India, South-East Asia, Middle East & Africa, CBRE, highlights Hyderabad’s growing…
Alembic Pharmaceuticals receives US FDA approval for Doxorubicin Hydrochloride Liposome injection
Alembic secures final US FDA approval for generic version of Doxil Liposome Injection used in ovarian cancer, AIDS-related…
Nontuberculous mycobacteria market to reach $4.6 billion in 7MM in 2033, forecasts GlobalData
Market expansion driven by novel pipeline drugs and rising diagnosed prevalence, but generic competition may limit uptake of…
Biocon Biologics expands insulin access in Malaysia
Public-private partnership with Malaysian government supports over 345,000 patients, strengthens local manufacturing and insulin…
Torrent Pharmaceuticals to acquire controlling stake in JB Pharma from KKR for ₹25,689 crore,…
Torrent to first acquire 46.39 per cent stake in JB Pharma and initiate open offer, aiming to integrate operations through merger…
Diagnosed prevalent cases of multiple sclerosis to increase by 0.19 per cent AGR in 7MM during…
GlobalData report highlights rising diagnosed prevalence of multiple sclerosis in the US, with middle-aged adults showing the…
Health Canada approves Biocon Biologics’ YESAFILI, first EYLEA biosimilar, for launch in July 2025
YESAFILI becomes Biocon Biologics’ tenth biosimilar to be commercialised globally, with Canada as the first launch market